Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan;31(1):64-70.
doi: 10.1089/AID.2014.0133.

Healthy HIV-1-infected individuals on highly active antiretroviral therapy harbor HIV-1 in their alveolar macrophages

Affiliations

Healthy HIV-1-infected individuals on highly active antiretroviral therapy harbor HIV-1 in their alveolar macrophages

Sushma K Cribbs et al. AIDS Res Hum Retroviruses. 2015 Jan.

Abstract

In a prospective cross-sectional study we quantified HIV viral load within the alveolar macrophage in a cohort of healthy HIV-infected subjects who did not have medical comorbidities or smoke cigarettes to determine if alveolar macrophage proviral DNA was associated with alveolar macrophage phagocytic immune dysfunction. We enrolled 23 subjects who underwent bronchoscopy and bronchoalveolar lavage. Alveolar macrophages were isolated and HIV-1 RNA was quantified in the cells using the Abbott RealTime HIV-1 Assay. Proviral DNA was qualitatively measured using a modified version of the HIV-1 RNA assay. Phagocytosis measured by incubating alveolar macrophages with FITC-labeled Staphylococcus aureus and determining fluorescence with a Zeiss inverted microscope. Phagocytic index was calculated as (% positive cells × mean channel fluorescence)/100. Sixteen subjects had (+) proviral DNA and seven had (-) proviral DNA in their alveolar macrophages. Of all subjects 100% in both groups were on highly active antiretroviral therapy (HAART). The median plasma viral load was 0 in both groups. HIV-1-infected subjects with (+) proviral DNA in their alveolar macrophages had a significantly lower median alveolar macrophage phagocytic index compared to those with (-) proviral DNA in their alveolar macrophages [11.8 (IQR 4.8-39.0) vs. 64.9 (IQR 14.0-166.0), p = 0.05]. Alveolar macrophages harbor HIV even in otherwise healthy subjects with undetectable plasma viral loads, representing a potential reservoir for the virus. In addition, HIV viral replication within the macrophage may impair phagocytosis and other immune functions in the lung, leading to an increased risk for lung infection.

PubMed Disclaimer

Figures

<b>FIG. 1.</b>
FIG. 1.
HIV proviral DNA and RNA are detectable and quantifiable in alveolar macrophages. Alveolar macrophages were isolated from otherwise healthy HIV-infected subjects. The Abbott RealTime HIV-1 Assay was used to measure both HIV DNA and RNA.
<b>FIG. 2.</b>
FIG. 2.
Proviral DNA within alveolar macrophages is associated with decreased bacterial phagocytosis. Alveolar macrophages were isolated from otherwise healthy HIV-infected subjects and incubated with FITC-labeled S. aureus. Phagocytosis was determined by measuring fluorescence with a Zeiss inverted microscope. The phagocytic index was calculated as (% positive cells×mean channel fluorescence)/100. The Abbott RealTime HIV-1 Assay was used to measure HIV proviral DNA.

Similar articles

Cited by

References

    1. El-Sadr WM, Lundgren JD, Neaton JD, et al. : CD4+count-guided interruption of antiretroviral treatment. N Engl J Med 2006;355(22):2283–2296 - PubMed
    1. Gordin FM, Roediger MP, Girard PM, et al. : Pneumonia in HIV-infected persons: Increased risk with cigarette smoking and treatment interruption. Am J Respir Crit Care Med 2008;178(6):630–636 - PMC - PubMed
    1. Jordano Q, Falco V, Almirante B, et al. : Invasive pneumococcal disease in patients infected with HIV: Still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis 2004;38(11):1623–1628 - PubMed
    1. Crothers K, Huang L, Goulet JL, et al. : HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 2011;183(3):388–395 - PMC - PubMed
    1. Murphy J, Summer R, Wilson AA, Kotton DN, and Fine A: The prolonged life-span of alveolar macrophages. Am J Respir Cell Mol Biol 2008;38(4):380–385 - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources